Back to Journals » Drug Design, Development and Therapy » Volume 12
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Aldoxorubicin: a tumor-targeted doxorubicin conjugate for relapsed or refractory soft tissue sarcomas
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
22,982 | Dovepress* | 18,669+ | 1,504 | 20,173 | |
PubMed Central* | 4,313 | 926 | 5,239 | ||
Totals | 22,982 | 2,430 | 25,412 | ||
*Since 6 April 2018 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
36 | 1 | 0 | 0 | 12 | 23 |
View citations on PubMed Central and Google Scholar